Cancer immunotherapy research is one of IDIBAPS pillars, recently reinforced by funding from the Spanish Association Against Cancer (AECC). The new group will apply advanced AI methodologies to integrate and analyze clinical and multiomic data, contributing to identifying biomarkers and new therapeutic targets. In addition, the group will collaborate with leading research teams in liver cancer, breast cancer, and lymphoid neoplasms.
IDIBAPS offers an interdisciplinary research environment at the Barcelona Clinical Campus, access to high-quality clinical and genomic data and advanced technological platforms, competitive funding, and professional institutional support.
Submission of applications:
Deadline: Until April 14, 2025
Sending applications: FCRBRRHH@recerca.clinic.cat
Questions: coordinacio.cientifica@recerca.clinic.cat
For more information, visit the IDIBAPS website: IDIBAPS Work with us.
